Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Cosentyx
Secukinumab 150mg
Powder for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Cosentyx
Secukinumab 150mg/mL
Solution for injection
Novartis New Zealand Limited
Novartis Pharma Stein AG, Stein, Switzerland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
MYTIB
Imatinib mesilate 119.5mg equivalent to Imatinib free base 100mg
Capsule
Douglas Pharmaceuticals Limited
Nobilus Ent, Jablonna, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
MYTIB
Imatinib mesilate 478mg equivalent to Imatinib free base 400mg
Capsule
Douglas Pharmaceuticals Limited
Nobilus Ent, Jablonna, Poland
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Rocuronium bromide
Rocuronium bromide 10mg/mL
Solution for injection
Max Health Limited
Hameln Pharmaceuticals GmbH, Hameln, Germany
|
Dated this 8th day of January 2016.
DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz